Charles River Laboratories Competitors and Similar CompaniesClear all

Charles River Laboratories's competitors and similar companies include SNBL, Eurofins, ICON, Fortrea US, Envigo and IQVIA.

	Charles River Laboratories Charles River Laboratories International is a company that provides drug discovery and non-clinical development solutions.	SNBL SNBL (Shin Nippon Biomedical Laboratories, 株式会社新日本科学) is a contract research company specializing in preclinical and clinical studies.	Eurofins Eurofins Scientific is a life sciences company providing laboratory services.	ICON ICON is a clinical research organization that provides consulting, outsourced development, and commercialization services.	Fortrea US Fortrea US (formerly known as Labcorp Drug Development) is a company that specializes in clinical development and patient access solutions.	Envigo Envigo is a company that provides research models and services.	IQVIA IQVIA Holdings (formerly known as QuintilesIMS) is a company that offers clinical research services, data analysis, and information solutions for the life sciences and healthcare industries.
Founding Date	Founding Date 1947	Founding Date 1957	Founding Date 1987	Founding Date 1990	Founding Date 1993	Founding Date 2015	Founding Date 2016
Type	Type Public	Type Public	Type Public	Type Public	Type Subsidiary	Type Subsidiary	Type Public
Tags	Tags Healthcare clinical research healthcare staffing medical diagnostics	Tags Healthcare clinical research	Tags Healthcare biotech clinical research compliance life sciences	Tags Healthcare biotech clinical research medical imaging outsourcing	Tags Healthcare clinical research drug development pharma	Tags Healthcare biotech clinical research drug development genetics pharma	Tags Technology clinical research cloud services(SaaS)data collection data management enterprise software healthtech platform
Locations	Locations Wilmington, US HQ Melbourne, AU Beerse, BE Brussels, BE São Paulo, BR Laval, CA Saint Constant, CA see more	Locations Tokyo, JP HQ Kagoshima, JP Kainan, JP Osaka, JP Everett, US San Luis, US	Locations Luxembourg, LU HQ Girraween, AU Leoben, AT Villach, AT Zinj, BH Baipayl, BD Brussels, BE see more	Locations Dublin, IE HQ Villa Adelina, AR Sydney, AU Vienna, AT Minsk, BY Minsk, BY Mechelen, BE see more	Locations Durham, US HQ	Locations Indianapolis, US HQ Gannat, FR Jerusalem, IL Bresso, IT Desio, IT Udine, IT Horst, NL see more	Locations Durham, US HQ Buenos Aires, AR Melbourne, AU North Sydney, AU Wien, AT Antwerpen, BE Wijnegem, BE see more
Employees	Employees 18,3002% decrease	Employees 1,436	Employees 65,0004% increase	Employees 41,250	Employees 15,099	Employees 503	Employees 93,000
Valuation ($)	Valuation ($) 9.6 b	Valuation ($) 337.1 m	Valuation ($) 9.5 b	Valuation ($) 19.2 b	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 39.4 b
Financial
Revenue (est.)	Revenue (est.) $4b (FY, 2025)	Revenue (est.) ¥32.5b (FY, 2026)	Revenue (est.) €7.3b (FY, 2025)	Revenue (est.) $8.3b (FY, 2025)	Revenue (est.) $5.7b (FY, 2022)	Revenue (est.) N/A	Revenue (est.) $16.3b (FY, 2025)
Cost of goods	Cost of goods $2.7b (FY, 2025)	Cost of goods ¥13.3b (FY, 2026)	Cost of goods €2.3b (FY, 2025)	Cost of goods $6.1b (FY, 2025)	Cost of goods N/A	Cost of goods N/A	Cost of goods $10.9b (FY, 2025)
Gross profit	Gross profit $1.3b (FY, 2025)	Gross profit ¥19.3b (FY, 2026)	Gross profit €5b (FY, 2025)	Gross profit $2.2b (FY, 2025)	Gross profit N/A	Gross profit N/A	Gross profit $5.4b (FY, 2025)
Net income	Net income ($142.2m) (FY, 2025)	Net income ¥4.5b (FY, 2026)	Net income €473m (FY, 2025)	Net income $229.3m (FY, 2025)	Net income N/A	Net income N/A	Net income $1.4b (FY, 2025)
Operating ⚠
Countries	Countries 20 (FY, 2021)	Countries N/A	Countries 62 (FY, 2023)	Countries 53 (FY, 2021)	Countries N/A	Countries N/A	Countries 100 (FY, 2022)
Funding
Total funding raised	Total funding raised $ 34m	Total funding raised N/A	Total funding raised $ 30m	Total funding raised N/A	Total funding raised $ 1.3m	Total funding raised N/A	Total funding raised $ 3.2b